Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
220.00    -1.00 (-0.45%)
Bid:
217.00
Ask:
231.00
Spread: 14.00 (6.452%)
Market Cap: £116.15m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Statement regarding Elektron Technology plc

17 Jun 2014 07:00

RNS Number : 7602J
Microgen PLC
17 June 2014
 

microgen

www.microgen.com

 

17 June 2014

 

 

 

STATEMENT REGARDING ELEKTRON TECHNOLOGY PLC

 

Announcement falling under Rule 2.8 of the City Code on Takeovers and Mergers (the "Code")

 

Microgen plc ("Microgen") announced its interest in exploring opportunities consistent with the Elektron Technology plc ("Elektron") Strategic Alternatives Process ("SAP") on 20 May 2014 and provided a further update on 27 May 2014.

 

Microgen submitted its original proposal to the Board of Elektron on 2 May 2014 ("Refinancing Proposal"). The Refinancing Proposal indicated, subject to due diligence information being provided and other terms typical of a transaction of this nature, that Microgen could make a potential equity-based investment of between £12 million and £18 million and that Elektron would remain listed on AIM. Further information in respect of this proposal was detailed in Microgen's announcement of 20 May 2014.

 

The Refinancing Proposal was rejected by the Board of Elektron on 7 May 2014 who also then advised that, contrary to the SAP announcement, only offers for the entire issued share capital of Elektron would be considered. Following Microgen's announcement of 20 May 2014, access to due diligence information was progressed allowing Microgen to determine whether or not it was able to submit such an offer.

 

Whilst Microgen's preferred structure remains the Refinancing Proposal, on 11 June 2014 Microgen submitted to the Board of Elektron a non-binding letter with details of a potential offer by Microgen for the entire issued share capital of Elektron ("Offer Proposal"). Microgen's Offer Proposal was, subject to a number of conditions typical of a transaction of this nature, to make an offer for all of the issued equity of Elektron at a price of 5 pence per share in cash. This would represent:

 

· A value for the existing issued ordinary share capital of Elektron of approximately £6.0 million equivalent to an enterprise value for Elektron, adjusting for net debt at 30 April 2014, of £13.6 million. (The level of investment required under the Offer Proposal (enterprise value of £13.6 million) is similar in value to that of the Refinancing Proposal (£12 million to £18 million), taking into account investment in additional growth opportunities.)

 

· A premium of approximately 17.6% to the mid-market closing share price of 4.25 pence per Elektron share on 16 June 2014

 

Whilst Microgen's Offer Proposal would have sought to acquire 100% of the issued Elektron shares, any offer would have been declared unconditional as to acceptances once Microgen had received valid acceptances and/or acquired voting share rights representing in excess of 75% of the issued Elektron shares. Microgen's offer would have been funded from Microgen's existing cash resources. The Board of Elektron rejected Microgen's Offer Proposal on 13 June 2014 and did not express any interest in reconsidering Microgen's Refinancing Proposal.

 

Microgen considers that its Offer Proposal reflected fair, and arguably generous, value for Elektron shareholders. However, without a recommendation from the Board of Elektron, Microgen confirms that it is inappropriate to proceed with its Offer Proposal at the present time and therefore Microgen does not intend to make an offer for Elektron. Similarly Microgen cannot proceed with its Refinancing Proposal without the support of the Elektron Board.

 

Microgen stated in its announcement of 20 May 2014 that the Refinancing Proposal, with its investment in the £12 million to £18 million range, "offered Elektron shareholders the opportunity to share in the Elektron recovery from a stable financial platform." Microgen also stated in its announcement of 20 May 2014 that "In view of the cash resources absorbed by Elektron in recent years, the continuing deterioration of Elektron's financial position and the proven inability of Elektron to forecast future business prospects, should Elektron receive only a limited cash injection, this may only provide short-term relief and may not provide the confidence required with non-equity stakeholders (customers, suppliers, banks, employees) to enable Elektron to rebuild". It is therefore disappointing that the Board of Elektron have decided not to progress either of the Microgen proposals.

 

Under Rule 2.8 of the Code, and except with the consent of the Panel, the statement that Microgen does not intend to make an offer for Elektron will prevent Microgen, or anyone acting in concert with it (or any person who is subsequently acting in concert with it or them), from announcing an offer or possible offer for Elektron or taking certain other action within the next six months unless there is, in the opinion of the Panel, a material change of circumstances or there has occurred an event which is specified in Note 2 of Rule 2.8 as enabling this statement to be set aside. Accordingly, for the purposes of Rule 2.8, Microgen reserves the right (on behalf of itself and anyone acting in concert with it) to announce an offer or possible offer for Elektron and/or to take any other action which would otherwise be restricted under Rule 2.8 within the next six months in circumstances set out in Note 2 of Rule 2.8.

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

 

Rowena Murray, Investec Bank plc 020-7597-5970

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRXQLLFZQFLBBL
Date   Source Headline
24th Mar 201112:22 pmRNSAnnual Information Update
2nd Mar 201110:11 amRNSHolding(s) in Company
28th Feb 201110:15 amRNSTotal Voting Rights
25th Feb 201111:53 amRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSFinal Results
16th Feb 20113:18 pmRNSNotice of Results
3rd Feb 20115:00 pmRNSHolding(s) in Company
3rd Feb 20114:58 pmRNSHolding(s) in Company
28th Jan 201112:59 pmRNSHolding(s) in Company
17th Jan 20114:18 pmRNSDirector Declaration
14th Jan 20114:18 pmRNSHolding(s) in Company
10th Jan 20117:00 amRNSPre-close Trading Update
7th Jan 201111:49 amRNSBlocklisting Return
7th Jan 201111:48 amRNSBlocklisting Return
4th Jan 201110:10 amRNSTotal Voting Rights
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
3rd Nov 20103:40 pmRNSHolding(s) in Company
29th Oct 201010:00 amRNSTotal Voting Rights
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
30th Sep 20107:00 amRNSTotal Voting Rights
29th Sep 20108:05 amRNSDirector/PDMR Shareholding
27th Sep 20107:01 amRNSBlocklisting Interim Review
23rd Sep 201010:59 amRNSApplication for Blocklisting
15th Sep 20107:00 amRNSMicrogen Aptitude Modules Launch
9th Sep 20102:37 pmRNSHolding(s) in Company
6th Sep 201012:38 pmRNSHolding(s) in Company
2nd Sep 20104:32 pmRNSHolding(s) in Company
31st Aug 20101:19 pmRNSTotal Voting Rights
23rd Aug 20102:12 pmRNSDirector/PDMR Shareholding
23rd Aug 20107:00 amRNSResult of Tender Offer
19th Aug 201010:09 amRNSGM Announcement
11th Aug 201011:16 amRNSHolding(s) in Company
2nd Aug 20101:15 pmRNSPosting of Shareholder Circular
26th Jul 201012:49 pmRNSHolding(s) in Company
22nd Jul 20107:00 amRNSInterim Results
14th Jul 20103:30 pmRNSNotice of Results
1st Jul 201012:51 pmRNSBlocklisting Interim Review
1st Jul 201012:46 pmRNSBlocklisting Interim Review
24th Jun 20104:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20104:38 pmRNSHolding(s) in Company
1st Jun 20102:14 pmRNSDirector Declaration
4th May 20109:57 amRNSTotal Voting Rights
27th Apr 201012:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20102:41 pmRNSDirector/PDMR Shareholding
22nd Apr 20107:00 amRNSInterim Management Statement
16th Apr 20101:56 pmRNSDirector Declaration
22nd Mar 201010:03 amRNSAGM Statement
18th Mar 201011:33 amRNSAnnual Information Update
16th Mar 20105:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.